The state of mental health equity
Insights from clinical experts focused on improving mental health disparities.
![](https://cdn.prod.website-files.com/65d5520ef65eaba833ec52bb/65d5520ef65eaba833ec5594_Screen-Shot-2021-11-22-at-6.00.39-PM-912x512.png)
Cultivating equitable mental health in the workplace can feel like an insurmountable challenge. But most big transformations come from the hundreds of small steps we take along the way. Mental health equity is no different.
“Beyond in-person therapy, there are digital options that can reach communities of color in a more discrete, destigmatized, and consistent manner. Research has shown that 55% of patients prefer digital tools, but to reach and effectively support people of color, important solutions like digital therapeutics need to be built on the foundation of culturally sensitive frameworks and be clinically proven through research”Dr. Juliette McClendon
— Big Health’s Director of Medical Affairs
This report demystifies what mental health equity means, the important role employers have in foster it, and practical (small) steps to do so.
Key learnings:
- The difference between equity and equality
- Distinct ways mental health care disparities show up for marginalized populations
- Why these inequities exist
- The role employers can play in dismantling deep-seated inequities
A peek inside:
![](https://cdn.prod.website-files.com/65d5520ef65eaba833ec52bb/65d5520ef65eaba833ec556e_Fan-of-handout-1024x616.png)
Download the report
During the COVID-19 public health emergency, Sleepio and Daylight are being made available as treatments for insomnia disorder and generalized anxiety disorder (GAD), respectively, without a prescription. Sleepio and Daylight have not been cleared by the U.S. Food and Drug Administration (FDA) for the treatment of insomnia disorder and GAD, respectively.
1. Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., & Denberg, T. D. (2016). Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine, 165(2), 125-133.2. Riemann, D., Baglioni, C., Bassetti, C., Bjorvatn, B., Dolenc Groselj, L., Ellis, J. G., … & Spiegelhalder, K. (2017). European guideline for the diagnosis and treatment of insomnia. Journal of Sleep Research, 26(6), 675-700.3. Wilson, S., Anderson, K., Baldwin, D., Dijk, D. J., Espie, A., Espie, C., … & Sharpley, A. (2019). British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: an update. Journal of Psychopharmacology, 33(8), 923-947.4. King’s Technology Evaluation Centre. (2017, November 9). Overview: Health app: SLEEPIO for adults with poor Sleep: Advice. NICE. https://www.nice.org.uk/advice/mib129.5. Espie, C. A., Kyle, S. D., Williams, C., Ong, J. C., Douglas, N. J., Hames, P., & Brown, J. S. (2012). A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep, 35(6), 769-781.6. Carl, J. R., Miller, C. B., Henry, A. L., Davis, M. L., Stott, R., Smits, J. A., … & Espie, C. A. (2020). Efficacy of digital cognitive behavioral therapy for moderate‐to‐severe symptoms of generalized anxiety disorder: A randomized controlled trial. Depression and Anxiety, 37(12), 1168-1178.
DOC-3046 Effective 11/2023